Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Glioblastoma 2 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Kidney Neoplasms 1 Ketogen-based Therapeutic Diet 1 Estrogen Receptor-positive Breast Cancer 1 Endometrial Neoplasms 1

Interventions

aldesleukin 26 Sunitinib 25 Interferon-alpha 21 Everolimus 18 Sorafenib 16 Cyclophosphamide 16 Filgrastim 13 Bevacizumab 13 Nivolumab 11 Gemcitabine 11 Interleukin-2 10 Axitinib 10 fludarabine phosphate 9 Gene Expression Profiling 9 temsirolimus 8 Peripheral Blood Stem Cell Transplantation 8 Doxorubicin 8 pembrolizumab 7 Radiotherapy 6 Radiosurgery 6 Polymerase Chain Reaction 6 Ipilimumab 6 Carboplatin 6 sargramostim 5 Ifosfamide 5 Fluorouracil 5 Erlotinib Hydrochloride 5 Capecitabine 5 Bortezomib 5 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Kidney Neoplasms × Diet, Ketogenic × Clear all

NCT04316520 2024-08-16

CETOREIN

University Hospital, Angers

Phase NA Completed

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡